Muna Qayed

SOM: Peds: BMT
Professor

mqayed@emory.edu

Academic Appointment

Associate Professor of Pediatrics, Emory University School of Medicine

Education

Degrees

MBBS from University of Jordan
MSCR from Emory University

Research

Focus

Pediatric solid tumor oncology and Hematopoeitic stem cell transplantation: - Incorporation of novel agents into the treatment of relapsed solid tumors, and improving current treatments for patients with high risk disease including autologous stem cell transplantation. Currently the PI of an institutional phase I dose escalation trial using Sirolimus in combination of metronomic chemotherapy for relapsed and refractory solid tumors.
Developing more effective prophylaxis/ treatment against graft versus host disease (GVHD) in patients undergoing allogeneic blood and marrow transplant, and incorporating biomarkers for early diagnosis. Currently leading the effort to establish an institutional biorepository of BMT patient samples linked to clinical data.

Publications

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.
Nat Commun Volume: 16 Page(s): 4114
05/02/2025 Authors: Mumme HL; Huang C; Ohlstrom D; Bakhtiari M; Raikar SS; DeRyckere D; Qayed M; Castellino SM; Wechsler DS; Porter CC
Umbilical Cord Blood Reduced Relapse but Increased Nonrelapse Mortality Compared to Matched Unrelated Donor Transplantation in Pediatric Acute Myeloid Leukemia With Active Disease: A CIBMTR 2008 to 2017 Analysis of Donor Source and Residual Disease.
Transplant Cell Ther Volume: 31 Page(s): 261.e1 - 261.e15
04/01/2025 Authors: Takahashi T; Wachter F; Alvarez Calderon F; Kapadia M; Qayed M; Keating AK
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.
Transplant Cell Ther Volume: 31 Page(s): 224.e1 - 224.e13
04/01/2025 Authors: Rotz SJ; Wiener L; Baker KS; Choi SW; Phelan R; Cuvelier GDE; Duncan C; Williams KM; Qayed M
Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy.
Blood Adv
03/24/2025 Authors: Lust H; Schultz LM; Kwon S; Roloff GW; Aldoss I; Baggott C; John S; Rossoff J; McNerney KO; Fabrizio VA
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.
Blood Adv Volume: 9 Page(s): 1040 - 1048
03/11/2025 Authors: Pidala J; Kim J; Kalos D; Cutler C; DeFilipp Z; Flowers MED; Hamilton BK; Chin K-K; Rotta M; El Jurdi N
Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma?
Pediatr Hematol Oncol Volume: 42 Page(s): 63 - 67
02/01/2025 Authors: Knight TE; Broglie L; Sharma A; Qayed M; Yanik GA
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
Transplant Cell Ther Volume: 31 Page(s): 109.e1 - 109.e13
02/01/2025 Authors: Takahashi T; Watkins B; Bratrude B; Neuberg D; Hebert K; Betz K; Yu A; Choi SW; Davis J; Duncan C
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group.
Transplant Cell Ther Volume: 31 Page(s): 10.e1 - 10.e9
01/01/2025 Authors: Katsivelos N; Spyrou N; Weber D; Vasova I; Ayuk F; Choe H; Hogan W; DeFilipp Z; Qayed M; Etra AM
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients.
Transplant Cell Ther Volume: 30 Page(s): 1061.e1 - 1061.e10
11/01/2024 Authors: Rios CAO; Qayed M; Etra AM; Reshef R; Newcomb R; Yuhasz N; Hexner EO; Aguayo-Hiraldo P; Merli P; Hogan WJ
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
Blood Volume: 144 Page(s): 1834 - 1845
10/24/2024 Authors: Kean LS; Burns LJ; Kou TD; Kapikian R; Lozenski K; Langston A; Horan JT; Watkins B; Qayed M; Bratrude B
Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
Transplant Cell Ther Volume: 30 Page(s): 929.e1 - 929.e6
09/01/2024 Authors: Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD.
Blood Volume: 144 Page(s): 1010 - 1021
08/29/2024 Authors: Akahoshi Y; Spyrou N; Weber D; Aguayo-Hiraldo P; Ayuk F; Chanswangphuwana C; Choe HK; Eder M; Etra AM; Grupp SA
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD.
Blood Adv Volume: 8 Page(s): 3488 - 3496
07/09/2024 Authors: DeFilipp Z; Kim HT; Spyrou N; Katsivelos N; Kowalyk S; Eng G; Kasikis S; Beheshti R; Baez J; Akahoshi Y
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.
Nat Med Volume: 30 Page(s): 1982 - 1993
07/01/2024 Authors: Zinter MS; Dvorak CC; Mayday MY; Reyes G; Simon MR; Pearce EM; Kim H; Shaw PJ; Rowan CM; Auletta JJ
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-Asecondary CIBMTR analysis.
Br J Haematol Volume: 205 Page(s): 243 - 255
07/01/2024 Authors: Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM
Amphiregulin, ST2, and REG3 biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.
Blood Adv Volume: 8 Page(s): 3284 - 3292
06/25/2024 Authors: Etra A; El Jurdi N; Katsivelos N; Kwon D; Gergoudis S; Morales G; Spyrou N; Kowalyk S; Aguayo-Hiraldo P; Akahoshi Y
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
Transplant Cell Ther Volume: 30 Page(s): 603.e1 - 603.e11
06/01/2024 Authors: Qayed M; Kapoor U; Gillespie S; Westbrook A; Aguayo-Hiraldo P; Ayuk FA; Aziz M; Baez J; Choe H; DeFilipp Z
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
Bone Marrow Transplant Volume: 59 Page(s): 680 - 687
05/01/2024 Authors: Gorfinkel L; Raghunandan S; Watkins B; Hebert K; Neuberg DS; Bratrude B; Betz K; Yu A; Choi SW; Davis J
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.
Blood Adv Volume: 8 Page(s): 2047 - 2057
04/23/2024 Authors: Akahoshi Y; Spyrou N; Hoepting M; Aguayo-Hiraldo P; Ayuk F; Chanswangphuwana C; Choe HK; Eder M; Etra AM; Grupp SA
A Day 14 Endpoint for Acute GVHD Clinical Trials.
Transplant Cell Ther Volume: 30 Page(s): 421 - 432
04/01/2024 Authors: Spyrou N; Akahoshi Y; Kowalyk S; Morales G; Beheshti R; Aguayo-Hiraldo P; Al Malki MM; Ayuk F; Bader P; Baez J
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
Nat Commun Volume: 15 Page(s): 2749
03/29/2024 Authors: Keller MD; Schattgen SA; Chandrakasan S; Allen EK; Jensen-Wachspress MA; Lazarski CA; Qayed M; Lang H; Hanley PJ; Tanna J
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Transplant Cell Ther Volume: 30 Page(s): 336.e1 - 336.e8
03/01/2024 Authors: Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
Am J Hematol Volume: 99 Page(s): 370 - 379
03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
Novel approaches to acute graft-versus-host disease prevention.
Hematology Am Soc Hematol Educ Program Volume: 2023 Page(s): 155 - 163
12/08/2023 Authors: Watkins B; Qayed M
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.
Volume: 58 Page(s): 1390 - 1393
12/01/2023 Authors: Knight TE; Ahn KW; Hebert KM; Atshan R; Wall DA; Chiengthong K; Lund TC; Prestidge T; Rangarajan HG; Dvorak CC
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients.
medRxiv
11/29/2023 Authors: Zinter MS; Dvorak CC; Mayday MY; Reyes G; Simon MR; Pearce EM; Kim H; Shaw PJ; Rowan CM; Auletta JJ
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
EClinicalMedicine Volume: 65 Page(s): 102268
11/01/2023 Authors: Barsan V; Li Y; Prabhu S; Baggott C; Nguyen K; Pacenta H; Phillips CL; Rossoff J; Stefanski H; Talano J-A
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
Bone Marrow Transplant Volume: 58 Page(s): 1264 - 1266
11/01/2023 Authors: Raghunandan S; Qayed M; Watkins BK; Graiser M; Gorfinkel L; Westbrook A; Gillespie S; Bratrude B; Petrovic A; Suessmuth Y
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS
Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
Pediatr Blood Cancer Volume: 70 Page(s): e30606
10/01/2023 Authors: Hughes C; Harris A; Watkins B; Qayed M; Parikh S; Horwitz E; Stenger E; Williams KM; Schoettler ML
The utility of biomarkers in acute GVHD prognostication.
Blood Adv Volume: 7 Page(s): 5152 - 5155
09/12/2023 Authors: Spyrou N; Akahoshi Y; Ayuk F; Holler E; Choe H; Etra A; Hogan WJ; Rsler W; Hexner E; DeFilipp Z
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood Volume: 142 Page(s): 700 - 710
08/24/2023 Authors: Takahashi T; Al-Kofahi M; Jaber M; Bratrude B; Betz K; Suessmuth Y; Yu A; Neuberg DS; Choi SW; Davis J
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.
Blood Adv Volume: 7 Page(s): 4479 - 4491
08/22/2023 Authors: Akahoshi Y; Spyrou N; Hogan WJ; Ayuk F; DeFilipp Z; Weber D; Choe HK; Hexner EO; Rsler W; Etra AM
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
Blood Adv Volume: 7 Page(s): 4395 - 4399
08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Blood Adv Volume: 7 Page(s): 2758 - 2771
06/27/2023 Authors: McNerney KO; Si Lim SJ; Ishikawa K; Dreyzin A; Vatsayan A; Chen JJ; Baggott C; Prabhu S; Pacenta HL; Philips C
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors.
Transplant Cell Ther Volume: 29 Page(s): 380.e1 - 380.e9
06/01/2023 Authors: Knight TE; Ahn KW; Hebert KM; Atshan R; Wall DA; Chiengthong K; Rotz SJ; Fraint E; Rangarajan HG; Auletta JJ
OPTIMIZING HAPLOIDENTICAL DONOR SELECTION FOR PEDIATRIC HEMATOPOIETIC CELL TRANSPLANT
Volume: 70 Page(s): S198 - S199
06/01/2023 Authors: Liberio N; Allbee-Johnson M; Atshan R; Ahn KW; Yanik G; Schultz K; Qayed M; Lipsitt A; Sharma A; Page K
DIFFUSE ALVEOLAR HEMORRHAGE IN CHILDREN AFTER HEMATOPOIETIC CELLULAR THERAPY: RISK FACTORS FOR MORTALITY AND RESPONSE RATES TO INHALED AGENTS
Volume: 70 Page(s): S218 - S219
06/01/2023 Authors: Schoettler ML; Dandoy C; Harris A; Chan M; Tarquinio K; Jodele S; Qayed M; Kamat P; Petrillo T; Perez J
DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
Volume: 70 Page(s): S214 - S215
06/01/2023 Authors: Yoo J; Obordo J; Schoettler M; Qayed M; Hughes K; Harris A; Spencer K; Parikh S; Chandrakasan S; Chonat S
IMPACT OF TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY AND ACUTE GRAFT VERSUS HOST DISEASE ON SURVIVAL IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC CELLULAR TRANSPLANTATION
Volume: 70 Page(s): S217 - S217
06/01/2023 Authors: Schoettler M; Harris A; Bryson E; Deeb L; Watkins B; Haight A; Parikh S; Chandrakasan S; Stenger E; Liang W
STEROID-ASSOCIATED ADVERSE EVENTS ARE DOSE-DEPENDENT FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION
Volume: 70 Page(s): S213 - S213
06/01/2023 Authors: Lisac R; Raghunandan S; Gillespie S; Liu K; Qayed M; Williams K; Watkins B
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
Blood Adv Volume: 7 Page(s): 2196 - 2205
05/23/2023 Authors: Stenger EO; Watkins B; Rogowski K; Chiang K-Y; Haight A; Leung K; Qayed M; Raghunandan S; Suessmuth Y; Kean L
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
Blood Adv Volume: 7 Page(s): 1784 - 1795
05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines.
Transplant Cell Ther Volume: 29 Page(s): 293 - 301
05/01/2023 Authors: Fraint E; Abdel-Azim H; Bhatt NS; Broglie L; Chattha A; Kohorst M; Ktena YP; Lee MA; Long S; Qayed M
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
J Immunother Cancer Volume: 11
05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
J Clin Oncol Volume: 41 Page(s): 1664 - 1669
03/20/2023 Authors: Laetsch TW; Maude SL; Rives S; Hiramatsu H; Bittencourt H; Bader P; Baruchel A; Boyer M; De Moerloose B; Qayed M
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Blood Adv Volume: 7 Page(s): 541 - 548
02/28/2023 Authors: Stefanski HE; Eaton A; Baggott C; Rossoff J; Verneris MR; Prabhu S; Pacenta HL; Phillips CL; Talano J-A; Moskop A
Effective treatment of low-risk acute GVHD withitacitinib monotherapy.
Blood Volume: 141 Page(s): 481 - 489
02/02/2023 Authors: Etra A; Capellini A; Alousi A; Al Malki MM; Choe H; DeFilipp Z; Hogan WJ; Kitko CL; Ayuk F; Baez J
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol Volume: 41 Page(s): 354 - 363
01/10/2023 Authors: Schultz LM; Eaton A; Baggott C; Rossoff J; Prabhu S; Keating AK; Krupski C; Pacenta H; Philips CL; Talano J-A
Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality.
Front Oncol Volume: 13 Page(s): 1232621
01/01/2023 Authors: Schoettler ML; Dandoy CE; Harris A; Chan M; Tarquinio KM; Jodele S; Qayed M; Watkins B; Kamat P; Petrillo T
Compassionate use narsoplimab to treat transplant associated thrombotic microangiopathy in a pediatric patient with multi-organ failure
Volume: 57 Page(s): 350 - 350
11/01/2022 Authors: Schoettler M; Bryson E; Deeb L; Qayed M; Watkins B; Chandrakasan S; Chonat S; Williams K
Overlap chronic graft-versus-host disease (GvHD) is associated aith an adverse prognosis: secondary analysis of the ABA2 trial
Volume: 57 Page(s): 41 - 41
11/01/2022 Authors: Gorfinkel L; Raghunandan S; Langston A; Westbrook A; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.
Cytotherapy Volume: 24 Page(s): 869 - 878
09/01/2022 Authors: Qayed M; McGuirk JP; Myers GD; Parameswaran V; Waller EK; Holman P; Rodrigues M; Clough LF; Willert J
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Blood Adv Volume: 6 Page(s): 4251 - 4255
07/26/2022 Authors: Moskop A; Pommert L; Baggott C; Prabhu S; Pacenta HL; Phillips CL; Rossoff J; Stefanski HE; Talano J-A; Margossian SP
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
Blood Adv Volume: 6 Page(s): 3707 - 3715
06/28/2022 Authors: Etra A; Gergoudis S; Morales G; Spyrou N; Shah J; Kowalyk S; Ayuk F; Baez J; Chanswangphuwana C; Chen Y-B
ABATACEPT FOR THE PREVENTION OF GVHD IN PEDIATRIC PATIENTS RECEIVING 7/8 HLA-MISMATCHED TRANSPLANT
Volume: 69
06/01/2022 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Betz K; Suessmuth Y; Gillespie S; Westbrook A; Williams K; Schoettler M; Langston A
REMISSION OF AML IN A PATIENT WITH GERMLINE TP53 MUTATION AFTER DECITABINE MONOTHERAPY
Volume: 69
06/01/2022 Authors: Sadanand A; Qayed M; Keller F
BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
Volume: 69
06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
REDUCING DURATION OF EMPIRIC ANTIBIOTICS IN CHILDREN UNDERGOING STEM CELL TRANSPLANTATION
Volume: 69
06/01/2022 Authors: Patel P; Teherani M; Xiang Y; Bernardo V; Chandrakasan S; Goggin K; Haight A; Horwitz E; Liang W; Parikh S
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia.
Leukemia Volume: 36 Page(s): 1508 - 1515
06/01/2022 Authors: Laetsch TW; Maude SL; Balduzzi A; Rives S; Bittencourt H; Boyer MW; Buechner J; De Moerloose B; Qayed M; Phillips CL
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
Blood Adv Volume: 6 Page(s): 3058 - 3061
05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Blood Adv Volume: 6 Page(s): 1961 - 1968
04/12/2022 Authors: Fabrizio VA; Boelens JJ; Mauguen A; Baggott C; Prabhu S; Egeler E; Mavroukakis S; Pacenta H; Phillips CL; Rossoff J
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
J Clin Oncol Volume: 40 Page(s): 945 - 955
03/20/2022 Authors: Schultz LM; Baggott C; Prabhu S; Pacenta HL; Phillips CL; Rossoff J; Stefanski HE; Talano J-A; Moskop A; Margossian SP
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
Blood Adv Volume: 6 Page(s): 746 - 749
02/08/2022 Authors: Qayed M; Watkins B; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C; Giller R; Grimley M
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Blood Adv Volume: 6 Page(s): 600 - 610
01/25/2022 Authors: Fabrizio VA; Phillips CL; Lane A; Baggott C; Prabhu S; Egeler E; Mavroukakis S; Pacenta H; Rossoff J; Stefanski HE
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease.
Front Immunol Volume: 13 Page(s): 959658
01/01/2022 Authors: Stenger E; Giver CR; Langston A; Kota D; Das PK; Chinnadurai R; Galipeau J; Waller EK; Qayed M
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
Blood Cancer Discov Volume: 3 Page(s): 66 - 81
01/01/2022 Authors: Pulsipher MA; Han X; Maude SL; Laetsch TW; Qayed M; Rives S; Boyer MW; Hiramatsu H; Yanik GA; Driscoll T
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Transplant Cell Ther Volume: 27 Page(s): 988.e1 - 988.e7
12/01/2021 Authors: Zewde MG; Morales G; Gandhi I; zbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Blood Volume: 138 Page(s): 2138 - 2142
11/25/2021 Authors: Rossoff J; Baggott C; Prabhu S; Pacenta H; Phillips CL; Stefanski H; Talano J-A; Moskop A; Margossian SP; Verneris MR
Real World Indications and use of Chimeric Antigen Receptor T Cell Therapy in Pediatric Patients with Relapsed or High-Risk Leukemia
Volume: 68 Page(s): S170 - S171
11/01/2021 Authors: Barsan V; Baggott C; Prabhu S; Pacenta H; Philips C; Rossoff J; Stefanski H; Talano J-A; Moskop A; Margossian S
Real World Treatment of Pediatric Patients with Down Syndrome and Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-All) Treated with Tisagenlecleucel
Volume: 68 Page(s): S87 - S88
11/01/2021 Authors: Pacenta H; Schultz L; Baggott C; Shah N; Prabhu S; Phillips C; Rossoff J; Stefanski H; Talano J-A; Moskop A
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia.
Curr Opin Hematol Volume: 28 Page(s): 373 - 379
11/01/2021 Authors: Qayed M; Bleakley M; Shah NN
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.
Bone Marrow Transplant Volume: 56 Page(s): 2869 - 2870
11/01/2021 Authors: Kasikis S; Baez J; Gandhi I; Grupp S; Kitko CL; Kowalyk S; Merli P; Morales G; Pulsipher MA; Qayed M
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
J Immunother Cancer Volume: 9
08/01/2021 Authors: Levine JE; Grupp SA; Pulsipher MA; Dietz AC; Rives S; Myers GD; August KJ; Verneris MR; Buechner J; Laetsch TW
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
J Clin Oncol Volume: 39 Page(s): 1865 - 1877
06/10/2021 Authors: Watkins B; Qayed M; McCracken C; Bratrude B; Betz K; Suessmuth Y; Yu A; Sinclair S; Furlan S; Bosinger S
Indole derivatives, microbiome and graft versus host disease.
Curr Opin Immunol Volume: 70 Page(s): 40 - 47
06/01/2021 Authors: Qayed M; Michonneau D; Soci G; Waller EK
RIFAXIMIN TO PREVENT BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Volume: 68 Page(s): S105 - S105
06/01/2021 Authors: Teherani M; Gillespie S; Pratte Z; Banksota S; Gulick D; Djeddar N; Chahroudi A; Horan J; Gibson G; Qayed M
FLUDARABINE-EXPOSURE PREDICTS DISEASE CONTROL FOLLOWING CD19-SPECIFIC CAR T CELL (TISAGENLECLEUCEL); A REPORT FROM PEDIATRIC REAL-WORLD CAR CONSORTIUM
Volume: 23 Page(s): S27 - S29
05/01/2021 Authors: Curran KJ; Fabrizio VA; Mauguen A; Boelens JJ; Baggott C; Prabhu S; Placenta H; Phillips CL; Rossoff J; Stefanski H
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
Blood Volume: 137 Page(s): 983 - 993
02/18/2021 Authors: Qayed M; Ahn KW; Kitko CL; Johnson MH; Shah NN; Dvorak C; Mellgren K; Friend BD; Verneris MR; Leung W
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.
Sci Transl Med Volume: 13
01/13/2021 Authors: Tkachev V; Kaminski J; Potter EL; Furlan SN; Yu A; Hunt DJ; McGuckin C; Zheng H; Colonna L; Gerdemann U
Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia.
Front Pediatr Volume: 9 Page(s): 784377
01/01/2021 Authors: Wlfl M; Qayed M; Benitez Carabante MI; Sykora T; Bonig H; Lawitschka A; Diaz-de-Heredia C
The Magic Biomarker Algorithm Predicts Outcomes for Children with Acute Graft Versus Host Disease
Volume: 55 Page(s): 81 - 82
12/01/2020 Authors: Qayed M; Kapoor U; Gillespie S; McCracken C; Abusin G; Aguayo-Hiraldo P; Ayuk F; Aziz M; Choe H; Grupp S
Potent Interaction between CMV Reactivation and Gvhd: Immunologic Evidence for Blunting of CMV-Driven Immune Reconstitution in the Setting of Gvhd
Volume: 136
11/05/2020 Authors: Suessmuth Y; Betz K; Yu A; Bratrude B; Watkins B; Qayed M; Horan JT; Kean L; Langston A
Predicting Immune Pathology after Hematopoietic Stem Cell Transplant with Transcriptomics: Naive CD4 T Cell Expansion at Day 100 Predicts Patients with De Novo Chronic Gvhd
Volume: 136
11/05/2020 Authors: Watkins B; Kaminski J; Qayed M; Betz K; Suessmuth Y; Bratrude B; Yu A; Tkachev V; Pellegrini K; Bosinger S
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant Volume: 26 Page(s): 1459 - 1468
08/01/2020 Authors: Im A; Rashidi A; Wang T; Hemmer M; MacMillan ML; Pidala J; Jagasia M; Pavletic S; Majhail NS; Weisdorf D
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant.
Leukemia Volume: 34 Page(s): 1898 - 1906
07/01/2020 Authors: Aziz MD; Shah J; Kapoor U; Dimopoulos C; Anand S; Augustine A; Ayuk F; Chaudhry M; Chen Y-B; Choe HK
Routine Surveillance Imaging Is Associated with Improved Postrelapse Survival in Patients with Ewing Sarcoma.
J Adolesc Young Adult Oncol Volume: 9 Page(s): 394 - 401
06/01/2020 Authors: Cash T; Bettermann EL; Mitchell S; McCracken C; Qayed M; Wolfe D; Alazraki A; Olson TA; Katzenstein HM
Development and validation of a pediatric disease risk index for allogeneic hematopoietic cell transplantation.
Volume: 38
05/20/2020 Authors: Qayed M; Kitko CL; Ahn KW; Johnson MH; Schultz KR; Smith AR; Yanik GA; Eapen M
Potent interaction between CMV reactivation and GVHD: Immunologic evidence for the blunting of CMV-driven immune reconstitution in the setting of GVHD in transplant patients
Volume: 204
05/01/2020 Authors: Suessmuth Y; Betz K; Yu A; Bratrude B; Watkins B; Qayed M; Horan J; Kean LS; Langston A
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
Volume: 67 Page(s): e28134
04/01/2020 Authors: Qayed M; Cash T; Tighiouart M; MacDonald TJ; Goldsmith KC; Tanos R; Kean L; Watkins B; Suessmuth Y; Wetmore C
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
Br J Haematol Volume: 189 Page(s): 162 - 170
04/01/2020 Authors: Nickel RS; Horan JT; Abraham A; Qayed M; Haight A; Ngwube A; Liang H; Luban NLC; Hendrickson JE
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease.
Blood Adv Volume: 3 Page(s): 4034 - 4042
12/10/2019 Authors: Srinagesh HK; zbek U; Kapoor U; Ayuk F; Aziz M; Ben-David K; Choe HK; DeFilipp Z; Etra A; Grupp SA
Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous Leukemia
Volume: 134
11/13/2019 Authors: Dahlberg A; Qayed M; Tarlock K; Pollard JA; Milano F; Meshinchi S; Delaney C
The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
Volume: 134
11/13/2019 Authors: Srinagesh H; Ozbek U; Kapoor U; Ayuk FA; Aziz MD; Ben-David K; Choe HK; Defilipp Z; Etra A; Grupp S
Transcriptomic Analysis of CD4+T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28:CD80/86 Costimulation Blockade with Abatacept
Volume: 134
11/13/2019 Authors: Watkins B; Suessmuth Y; Betz K; Yu A; Bratrude B; Qayed M; Pellegrini K; Bosinger S; Langston A; Horan JT
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant Volume: 25 Page(s): 1875 - 1883
09/01/2019 Authors: Saad A; Lamb L; Wang T; Hemmer MT; Spellman S; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Agrawal V
Potential utility of minimal residual disease (MRD) to identify relapse in pediatric and young adult (AYA) B-cell acute lymphoblastic leukemia (B-ALL) patients treated with tisagenlecleucel
Volume: 79
07/01/2019 Authors: Pulsipher MA; Han X; Quigley M; Kari G; Rives S; Laetsch TW; Myers GD; Hiramatsu H; Yanik GA; Qayed M
T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention in matched and mismatched unrelated donor transplantation: Results of the first phase 2 trial
Volume: 54 Page(s): 81 - 82
07/01/2019 Authors: Qayed M; Watkins B; Bratrude B; Betz K; Rhodes J; Sinclair S; Suessmuth Y; Yu A; Dean C; Cribbin K
Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.
Biol Blood Marrow Transplant Volume: 25 Page(s): 1099 - 1106
06/01/2019 Authors: Kilari D; D'Souza A; Fraser R; Qayed M; Davila O; Agrawal V; Diaz MA; Chhabra S; Cerny J; Copelan E
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
Blood Adv Volume: 3 Page(s): 1441 - 1449
05/14/2019 Authors: Mehta RS; Holtan SG; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Alousi AM; Pidala J; Abdel-Azim H
Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL).
Br J Haematol Volume: 185 Page(s): 613 - 616
05/01/2019 Authors: Miller L; Kobayashi S; Pauly M; Lew G; Saxe D; Keller F; Qayed M; Castellino S
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Lancet Oncol Volume: 20 Page(s): 719 - 727
05/01/2019 Authors: Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED
Disease Risk Index Predicts Relapse in Children Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)
Volume: 25
03/01/2019 Authors: Qayed M; Kapoor U; Gillespie S; Merli P; Pulsipher MA; Wolfl M; Kitko CL; Abusin G; Wudhikarn K; Schechter T
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant Volume: 25 Page(s): 73 - 85
01/01/2019 Authors: Chhabra S; Liu Y; Hemmer MT; Costa L; Pidala JA; Couriel DR; Alousi AM; Majhail NS; Stuart RK; Kim D
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
Blood Volume: 132 Page(s): 2506 - 2519
12/06/2018 Authors: Swimm A; Giver CR; DeFilipp Z; Rangaraju S; Sharma A; Ulezko Antonova A; Sonowal R; Capaldo C; Powell D; Qayed M
Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease
Volume: 132
11/29/2018 Authors: Aziz MD; Shah J; Kapoor U; Dimopoulos CN; Ayuk FA; Hogan WJ; Schreiner E; Choe HK; Chen Y-B; Hexner EO
Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia Patients Treated with Tisagenlecleucel
Volume: 132
11/29/2018 Authors: Pulsipher MA; Han X; Quigley M; Kari G; Rives S; Laetsch TW; Myers GD; Hiramatsu H; Yanik GA; Qayed M
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Nat Med Volume: 24 Page(s): 1504 - 1506
10/01/2018 Authors: Orlando EJ; Han X; Tribouley C; Wood PA; Leary RJ; Riester M; Levine JE; Qayed M; Grupp SA; Boyer M
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
JCI Insight Volume: 3
08/23/2018 Authors: Hartwell MJ; zbek U; Holler E; Renteria AS; Major-Monfried H; Reddy P; Aziz M; Hogan WJ; Ayuk F; Efebera YA
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
Blood Volume: 131 Page(s): 2846 - 2855
06/21/2018 Authors: Major-Monfried H; Renteria AS; Pawarode A; Reddy P; Ayuk F; Holler E; Efebera YA; Hogan WJ; Wlfl M; Qayed M
PANETH CELL COUNTS INDEPENDENTLY PREDICT ACUTE GASTROINTESTINAL GVHD STAGE AND RESPONSE TO THERAPY
Volume: 65
06/01/2018 Authors: Leblanc Z; Shehata B; Gillespie S; Farris A; Watkins B; Horan J; Qayed M
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.
Blood Adv Volume: 2 Page(s): 1022 - 1031
05/08/2018 Authors: Kumar AJ; Kim S; Hemmer MT; Arora M; Spellman SR; Pidala JA; Couriel DR; Alousi AM; Aljurf MD; Cahn J-Y
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant Volume: 24 Page(s): 726 - 733
04/01/2018 Authors: Kebriaei P; Anasetti C; Zhang M-J; Wang H-L; Aldoss I; de Lima M; Khoury HJ; Sandmaier BM; Horowitz MM; Artz A
Paneth Cell Counts Predict Severity of Gastrointestinal Acute Graft Versus Host Disease, Response to Treatment, and Mortality in Pediatric Bone Marrow Transplant Patients
Volume: 24 Page(s): S190 - S191
03/01/2018 Authors: LeBlanc Z; Shehata B; Gillespie S; Farris AB; Watkins BK; Horan J; Qayed M
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
Biol Blood Marrow Transplant Volume: 24 Page(s): 521 - 528
03/01/2018 Authors: Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M
Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: Comparison of two red blood cell depletion techniques.
Pediatr Blood Cancer Volume: 65
03/01/2018 Authors: Nickel RS; Qayed M; Worthington-White D; Stowell SR; Chiang K-Y
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.
Cell Rep Volume: 22 Page(s): 2504 - 2517
02/27/2018 Authors: Chinnadurai R; Rajan D; Qayed M; Arafat D; Garcia M; Liu Y; Kugathasan S; Anderson LJ; Gibson G; Galipeau J
Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT).
Volume: 36
02/20/2018 Authors: Kilari D; Hari P; Qayed M; Fraser R; Davila O; Kumar S; Mark TM; Nieto Y; D'Souza A
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med Volume: 378 Page(s): 439 - 448
02/01/2018 Authors: Maude SL; Laetsch TW; Buechner J; Rives S; Boyer M; Bittencourt H; Bader P; Verneris MR; Stefanski HE; Myers GD
Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.
Pediatr Blood Cancer Volume: 65
02/01/2018 Authors: Sano H; Hilinski JA; Qayed M; Applegate K; Newton JG; Watkins B; Chiang K-Y; Horan J
AFP as a Biologic Marker and Prognostic Factor in Newly-Diagnosed Completely Resected Hepatoblastoma
Volume: 64 Page(s): S71 - S72
11/01/2017 Authors: O'Neill A; Malogolowkin M; Krailo MD; Xia C; Qayed M; Langham MR; Meyers RL; Katzenstein HM
Respiratory Difficulties in Children With Underlying Asthma During Immunotherapy for High-risk Neuroblastoma.
J Pediatr Hematol Oncol Volume: 39 Page(s): e450 - e453
11/01/2017 Authors: Metrock LK; Qayed M; Simon D; Cash T; O'Connor MG; Johnson S; Esiashvili N; Katzenstein HM
Building blocks for institutional preparation of CTL019 delivery.
Cytotherapy Volume: 19 Page(s): 1015 - 1024
09/01/2017 Authors: McGuirk J; Waller EK; Qayed M; Abhyankar S; Ericson S; Holman P; Keir C; Myers GD
GLOBAL REGISTRATION TRIAL OF EFFICACY AND SAFETY OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): UPDATE TO THE INTERIM ANALYSIS
Volume: 102 Page(s): 178 - 178
06/26/2017 Authors: Buechner J; Grupp SA; Maude SL; Boyer M; Bittencourt H; Laetsch TW; Bader P; Verneris MR; Stefanski H; Myers GD
Improved survival after acute graft-versus-host disease diagnosis in the modern era.
Haematologica Volume: 102 Page(s): 958 - 966
05/01/2017 Authors: Khoury HJ; Wang T; Hemmer MT; Couriel D; Alousi A; Cutler C; Aljurf M; Antin JH; Ayas M; Battiwalla M
Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment
Volume: 23 Page(s): S92 - S94
03/01/2017 Authors: Major-Monfried H; Ozbek U; Renteria AS; Hartwell MJ; Pawarode A; Yanik GA; Ayuk F; Holler E; Efebera YA; Hogan WJ
An Early Biomarker Algorithm Predicts Lethal Graft-Vs-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation
Volume: 23 Page(s): S318 - S320
03/01/2017 Authors: Hartwell MJ; Ozbek U; Holler E; Renteria AS; Reddy P; Aziz M; Hogan WJ; Ayuk F; Efebera YA; Hexner EO
GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.
Bone Marrow Transplant Volume: 52 Page(s): 400 - 408
03/01/2017 Authors: Chen Y-B; Wang T; Hemmer MT; Brady C; Couriel DR; Alousi A; Pidala J; Urbano-Ispizua A; Choi SW; Nishihori T
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
JCI Insight Volume: 2 Page(s): e89798
02/09/2017 Authors: Hartwell MJ; zbek U; Holler E; Renteria AS; Major-Monfried H; Reddy P; Aziz M; Hogan WJ; Ayuk F; Efebera YA
African American Race Is a Newly Identified Risk Factor for Postengraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation.
Biol Blood Marrow Transplant Volume: 23 Page(s): 357 - 360
02/01/2017 Authors: Sano H; Hilinski JA; Applegate K; Chiang K-Y; Haight A; Qayed M; Horan J
Prolonged Isotretinoin in Ultra High-Risk Neuroblastoma.
J Pediatr Hematol Oncol Volume: 39 Page(s): e33 - e35
01/01/2017 Authors: Cash T; Alazraki A; Qayed M; Katzenstein HM
CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation
Volume: 128
12/02/2016 Authors: Sano H; Hilinski J; Applegate K; Camacho-Gonzalez A; Chandrakasan S; Chiang K-Y; Haight A; Krishnamurti L; Stenger E; Qayed M
Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation
Volume: 128
12/02/2016 Authors: Qayed M; Horan J; Spellman SR; Arora M; Wang T; Hemmer M; Pidala JA; Couriel D; Alousi AM
An Early Biomarker Algorithm Predicts Lethal Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation
Volume: 128
12/02/2016 Authors: Hartwell MJ; Ozbek U; Holler E; Renteria AS; Reddy PR; Aziz M; Hogan WJ; Ayuk FA; Efebera YA; Hexner EO
Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment
Volume: 128
12/02/2016 Authors: Major-Monfried H; Ozbek U; Renteria AS; Hartwell MJ; Pawarode A; Yanik GA; Ayuk FA; Holler E; Efebera YA; Hogan WJ
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.
Cancer Chemother Pharmacol Volume: 77 Page(s): 405 - 412
02/01/2016 Authors: Marachelian A; Desai A; Balis F; Katzenstein H; Qayed M; Armstrong M; Neville KA; Cohn SL; Bush M; Gunawan R
Clinically significant adverse events after major ABO mismatch BMT.
Bone Marrow Transplant Volume: 51 Page(s): 148 - 149
01/01/2016 Authors: Nickel RS; Waller EK; Qayed M; Chiang K-Y
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.
Biol Blood Marrow Transplant Volume: 22 Page(s): 4 - 10
01/01/2016 Authors: Harris AC; Young R; Devine S; Hogan WJ; Ayuk F; Bunworasate U; Chanswangphuwana C; Efebera YA; Holler E; Litzow M
Guidelines for the Standardization of Acute Graft-Versus-Host Disease Clinical Data Collection: An International Consensus Report
Volume: 126
12/03/2015 Authors: Harris AC; Young R; Devine SM; Hogan WJ; Ayuk F; Bunworasate U; Chanswangphuwana C; Efebera YA; Holler E; Litzow MR
Red Blood Cell Depletion for Pediatric Major ABO Mismatch BMT: Evaluation of the Risk of Hemolysis and Comparison of Two Techniques
Volume: 126
12/03/2015 Authors: Nickel RS; Dulson A; Worthington-White D; Qayed M; Chiang K-Y
Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
Biol Blood Marrow Transplant Volume: 21 Page(s): 1845 - 1852
10/01/2015 Authors: Stenger EO; Chiang K-Y; Haight A; Qayed M; Kean L; Horan J
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant Volume: 21 Page(s): 1273 - 1277
07/01/2015 Authors: Mehta PA; Zhang M-J; Eapen M; He W; Seber A; Gibson B; Camitta BM; Kitko CL; Dvorak CC; Nemecek ER
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR repertoire.
Blood Volume: 125 Page(s): 3835 - 3850
06/18/2015 Authors: Suessmuth Y; Mukherjee R; Watkins B; Koura DT; Finstermeier K; Desmarais C; Stempora L; Horan JT; Langston A; Qayed M
BONE MARROW MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH ACUTE AND CHRONIC GVHD DEPLOY NORMAL PHENOTYPE, DIFFERENTIATION PLASTICITY AND IMMUNE-SUPPRESSIVE ACTIVITY
CYTOTHERAPY Volume: 17 Page(s): S39 - S39
06/01/2015 Authors: Copland IB; Qayed M; Garcia M; Galipeau J; Waller E
Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
Biol Blood Marrow Transplant Volume: 21 Page(s): 934 - 940
05/01/2015 Authors: Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma.
J Pediatr Hematol Oncol Volume: 37 Page(s): 175 - 180
04/01/2015 Authors: Kandula S; Prabhu RS; Nanda R; Switchenko JM; Cash T; Qayed M; Katzenstein H; Esiashvili N
Comparison of survival at adult versus pediatric treatment centers for rare pediatric tumors in an adolescent and young adult (AYA) population in the State of Georgia.
Pediatr Blood Cancer Volume: 62 Page(s): 456 - 462
03/01/2015 Authors: Cash T; Qayed M; Ward KC; Mertens AC; Rapkin L
Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
Volume: 21 Page(s): S69 - S70
02/01/2015 Authors: Suessmuth Y; Koura D; Finstermeier K; Desmarais C; Horan J; Langston A; Qayed M; Khoury HJ; Watkins BK; Robins H
Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation.
Pediatr Blood Cancer Volume: 62 Page(s): 364 - 366
02/01/2015 Authors: Qayed M; Khurana M; Hilinski J; Gillespie S; McCracken C; Applegate K; Chiang K-Y; Horan J
The Role of Intestinal Microbiota in Graft versus Host Disease.
Mini Rev Med Chem Volume: 16 Page(s): 193 - 199
01/01/2015 Authors: Qayed M; Horan JT
Atypical Marginal Zone Hyperplasia Is a Mimic for Lymphoma in Pediatric Transplant Recipients: Report of Two Patients.
Pediatr Dev Pathol Volume: 18 Page(s): 416 - 421
01/01/2015 Authors: Caltharp SA; Qayed M; Park SI
Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in a Murine Model of Allogeneic Bone Marrow Transplantation
Volume: 124
12/06/2014 Authors: Waller EK; Giver CR; Rangaraju S; Swimm A; Sharma A; Qayed M; Defilipp Z; Kalman D
Relative defects in mucosal immunity predict acute graft-versus-host disease.
Biol Blood Marrow Transplant Volume: 20 Page(s): 1056 - 1059
07/01/2014 Authors: August KJ; Chiang K-Y; Qayed M; Dulson A; Worthington-White D; Cole CR; Horan JT
Treatment of hepatoblastoma with high-dose chemotherapy and stem cell rescue: the pediatric blood and marrow transplant consortium experience and review of the literature.
J Pediatr Hematol Oncol Volume: 36 Page(s): 362 - 368
07/01/2014 Authors: Karski EE; Dvorak CC; Leung W; Miller W; Shaw PJ; Qayed M; Katsanis E; Feusner JH
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1638 - 1649
11/01/2013 Authors: Koura DT; Horan JT; Langston AA; Qayed M; Mehta A; Khoury HJ; Harvey RD; Suessmuth Y; Couture C; Carr J
Outcomes After Definitive Radiation Treatment of Metastatic Sites in Patients With Stage IV Neuroblastoma
Volume: 87 Page(s): S599 - S599
10/01/2013 Authors: Kandula S; Prabhu RS; Katzenstein H; Qayed M; Esiashvili N
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.
Bone Marrow Transplant Volume: 48 Page(s): 1056 - 1064
08/01/2013 Authors: Hale GA; Arora M; Ahn KW; He W; Camitta B; Bishop MR; Bitan M; Cairo MS; Chan K; Childs RW
Dose-intensive cisplatin for hepatoblastoma: have you heard?
Lancet Oncol Volume: 14 Page(s): 791 - 792
08/01/2013 Authors: Qayed M; Katzenstein HM
Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation.
J Pediatr Hematol Oncol Volume: 35 Page(s): e149 - e152
05/01/2013 Authors: Qayed M; Langston A; Chiang K-Y; August K; Hilinski JA; Cole CR; Rogatko A; Bostick RM; Horan JT
A First-in-Disease Trial of in Vivo Costimulation Blockade for GVHD Prevention: The Addition of Abatacept to Standard GVHD Prophylaxis Controls Early CD4+T Cell Proliferation and is Associated with Low Rates of Severe Acute GVHD
Volume: 19 Page(s): S327 - S328
02/01/2013 Authors: Tiwari D; Horan J; Langston A; Qayed M; Carr J; Renfroe H; Couture C; Khoury HJ; Robertson J; Harvey D
Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization.
Fetal Pediatr Pathol Volume: 31 Page(s): 341 - 348
12/01/2012 Authors: Shulman SC; Katzenstein H; Bridge J; Bannister LL; Qayed M; Oskouei S; Shehata BM
Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.
Pediatr Blood Cancer Volume: 59 Page(s): 854 - 858
11/01/2012 Authors: Rapkin L; Qayed M; Brill P; Martin M; Clark D; George BA; Olson TA; Wasilewski-Masker K; Alazraki A; Katzenstein HM
Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma.
Pediatr Blood Cancer Volume: 58 Page(s): 448 - 452
03/01/2012 Authors: Qayed M; Chiang K-Y; Ricketts R; Alazraki A; Tahvildari A; Haight A; George B; Esiashvili N; Katzenstein HM
TARGETING MEMORY T CELLS WITH ALEFACEPT TO ABROGATE TRANSFUSION ALLOIMMUNIZATION: PRELIMINARY RESULTS FROM A TRIAL OF REDUCED INTENSITY CONDITIONING AND ALLOGENEIC TRANSPLANT FOR CHILDREN WITH NON-MALIGNANT HEMATOLOGIC DISEASES
Volume: 18 Page(s): S325 - S325
02/01/2012 Authors: Horan JT; Qayed M; Haight A; Couture C; Chiang KY; Kean L
CD28-DIRECTED T CELL COSTIMULATION BLOCKADE WITH ABATACEPT TO PREVENT GVHD DURING HIGH-RISK UNRELATED HSCT: A FIRST-IN-DISEASE TRIAL
Volume: 18 Page(s): S365 - S365
02/01/2012 Authors: Kean LS; Langston A; Qayed M; Khoury J; Tiwari D; Couture C; Renfroe H; Sen S; Robertson I; Waller EK
Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience
Volume: 118 Page(s): 1326 - 1326
11/18/2011 Authors: Hale GA; Grupp SA; Kasow KA; Bishop MR; Bitan M; Childs R; Copelan EA; Cairo MS; Camitta B; Chan KW
Red-Cell Transfusion Events as a Risk Factor for Sinusoidal Obstruction Syndrome in Children with Neuroblastoma Undergoing Hematopoietic Stem Cell Transplant
Volume: 51 Page(s): 113A - 113A
09/01/2011 Authors: Andrews JC; Qayed M; Applegate K; Jessup P; Horan J; Katzenstein H; Josephson C
LOWER OVERALL SURVIVAL IN AFRICAN AMERICAN PATIENTS UNDERGOING UNRELATED UMBILICAL CORD BLOOD TRANSPLANT: RESULTS OF A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 903 - 904
06/01/2011 Authors: Pauly M; Andrews J; Applegate K; Chiang K-Y; Couture C; Haight A; Li R; Kean L; Qayed M; Horan J
Platelet Transfusion Requirements Are Associated with Endothelial Cell Injury and Angiogenesis During Allogeneic Hematopoietic Stem Cell Transplantation
Volume: 116 Page(s): 1433 - 1433
11/19/2010 Authors: McPherson ME; Owusu BY; August KJ; Qayed M; Ilyles RH; Chiang K-Y; Khoury HJ; Ofori-Acquah SF; Horan J
Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation?
Pediatr Blood Cancer Volume: 55 Page(s): 199 - 201
07/15/2010 Authors: Qayed M; Thompson A; Applegate K; Haight A; Rogatko A; Chiang K-Y; Horan J
Tandem stem cell transplantation as consolidation therapy for high-risk neuroblastoma: The Children's Healthcare of Atlanta experience
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Qayed M; Chiang KY; Haight AE; George BA; Ricketts R; Alazraki A; Tahvildari A; Esiashvili N; Katzenstein HM
Irinotecan as maintenance therapy in high-risk hepatoblastoma.
Pediatr Blood Cancer Volume: 54 Page(s): 761 - 763
05/01/2010 Authors: Qayed M; Powell C; Morgan ER; Haugen M; Katzenstein HM
THE UPDATED SCHWARTZ FORMULA AS A SCREENING TEST FOR ABNORMAL KIDNEY FUNCTION PRIOR TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
Volume: 16 Page(s): S261 - S261
02/01/2010 Authors: Qayed M; Thompson A; Applegate K; Haight A; Chiang K-Y; Horan J
RIFAXIMIN FOR PREVENTING ACUTE GRAFT VERSUS HOST DISEASE: IMPACT ON PLASMA MARKERS OF INFLAMMATION AND T CELL ACTIVATION
Volume: 16 Page(s): S309 - S309
02/01/2010 Authors: Qayed M; Langston A; Chiang K-Y; Hilinski J; Cole C; McMillan S; Rowland P; Rogatko A; Horan J
Hypercalcemia in pediatric acute megakaryocytic leukemia: case report and review of the literature.
J Pediatr Hematol Oncol Volume: 31 Page(s): 373 - 376
05/01/2009 Authors: Qayed M; Ahmed I; Valentini RP; Cushing B; Rajpurkar M
Evolution of Combined Chemotherapy and Radiation for Pediatric Nasopharyngeal Carcinoma from Conventional 2-Dimensional Techniques to Intensity Modulated Radiation Therapy (IMRT): A 30-Year Experience from a Single Institution
Volume: 75 Page(s): S515 - S515
01/01/2009 Authors: Gatcombe HG; Qayed M; Katzenstein H; Olson T; Rapkin L; George B; Esiashvili N

Directory section navigation

Profile

Muna Qayed

Academic Appointment

Education

Degrees

Research

Focus

Publications